Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01250561 · ClinicalTrials.gov registry record · NA
Reduction of Postherpetic Neuralgia in Herpes Zoster
A NA study, sponsored by Center for Clinical Studies, Texas.
- Completed
- Registry status
- NA
- Development phase
- 133
- Enrollment target
NCT01250561 is a NA study that has completed, run by Center for Clinical Studies, Texas. The registered enrollment target is 133 participants.
The verdict
NCT01250561, a NA study, has completed, sponsored by Center for Clinical Studies, Texas.
- COMPLETED
- Registry status
- NA
- Development phase
- 133 participants
- Enrollment target
Study Summary
The addition of gabapentin therapy to standard antiviral treatment with valacyclovir in acute herpes zoster patients will decrease the incidence of post-herpetic neuralgia.
Interventions
- DRUG Valacyclovir
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2002-02 |
| Est. Completion | 2007-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01250561
The ClinicalTrials.gov registry entry for NCT01250561 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for Clinical Studies, Texas, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Valacyclovir is the first listed.
NCT01250561 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01250561 about?
NCT01250561 is a clinical study titled "Reduction of Postherpetic Neuralgia in Herpes Zoster". The addition of gabapentin therapy to standard antiviral treatment with valacyclovir in acute herpes zoster patients will decrease the incidence of post-herpetic neuralgia.
What is the current status of trial NCT01250561?
This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2002-02. Estimated completion is 2007-10.
What interventions are being tested in trial NCT01250561?
The interventions under investigation include: Valacyclovir (DRUG), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT01250561?
This trial is sponsored by Center for Clinical Studies, Texas, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.